➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Medtronic
Harvard Business School
Baxter
Colorcon

Last Updated: August 4, 2021

DrugPatentWatch Database Preview

TOBRAMYCIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Tobramycin patents expire, and when can generic versions of Tobramycin launch?

Tobramycin is a drug marketed by Alcon Pharms Ltd, Alembic Pharms Ltd, Apotex Inc, Bausch And Lomb, Fera Pharms, Gland Pharma Ltd, Somerset Theraps Llc, Akorn, Alkem Labs Ltd, Amneal Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, Lupin, Mylan, Sun Pharm, Teva Pharms Usa, Apothecon, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Mylan Labs Ltd, Watson Labs Inc, West-ward Pharms Int, Xellia Pharms Aps, and Xgen Pharms. and is included in forty-eight NDAs.

The generic ingredient in TOBRAMYCIN is tobramycin sulfate. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tobramycin

A generic version of TOBRAMYCIN was approved as tobramycin sulfate by WEST-WARD PHARMS INT on April 26th, 1991.

  Free Forever Trial

Drug patent expirations by year for TOBRAMYCIN
Drug Prices for TOBRAMYCIN

See drug prices for TOBRAMYCIN

Drug Sales Revenue Trends for TOBRAMYCIN

See drug sales revenues for TOBRAMYCIN

Recent Clinical Trials for TOBRAMYCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Colorado, DenverPhase 4
Denver Health and Hospital AuthorityPhase 4
Joint Purification SystemsPhase 3

See all TOBRAMYCIN clinical trials

Pharmacology for TOBRAMYCIN
Medical Subject Heading (MeSH) Categories for TOBRAMYCIN
Paragraph IV (Patent) Challenges for TOBRAMYCIN
Tradename Dosage Ingredient NDA Submissiondate
BETHKIS SOLUTION;INHALATION tobramycin 201820 2017-08-31
TOBI SOLUTION;INHALATION tobramycin 050753 2009-06-29

US Patents and Regulatory Information for TOBRAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 062945-002 Aug 9, 1989 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Hospira TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063111-001 Apr 30, 1991 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Fresenius Kabi Usa TOBRAMYCIN SULFATE (PHARMACY BULK) tobramycin sulfate INJECTABLE;INJECTION 065120-001 Nov 29, 2002 AP RX No Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
West-ward Pharms Int TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063118-001 Jul 29, 1991 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Gland Pharma Ltd TOBRAMYCIN SULFATE (PHARMACY BULK) tobramycin sulfate INJECTABLE;INJECTION 209346-001 Feb 9, 2021 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Medtronic
Harvard Business School
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.